License U of T Technologies

Who is this for?

Industry and other parties interested in licensing or otherwise using University of Toronto (U of T) technologies.

What do I need before I can begin?

There is no information required to begin. Please reach out to the Director, Innovations at 416-946-5515 if you have questions regarding licensing or using U of T technologies.

Licensing & Technology Opportunities

U of T is a global leader in turning research into products, services, companies and jobs. The Innovations & Partnerships Office (IPO) is your one-stop-shop to license these technologies and innovations from U of T. IPO’s team of licensing professionals make the process as quick and easy as possible.

Use our technology explorer to discover our startups, market-ready innovations, and licensing opportunities, or, contact us to discuss custom solutions.
 

Title Tech Opps Keywords
Targeting the Hippo Pathway for Cancer & Fibrosis Advanced Health Technologies , Biotechnology , Cancer , Cell Signaling , Drug Discovery , Health & Related Life Sciences , Inflammation , Pharmaceuticals , Small Molecules , Therapeutics 
Inhibition of PKN1 As Therapy For Chronic Lymphocytic Leukemia (CLL) Advanced Health Technologies , Biotechnology , Cancer , Drug Discovery , Health & Related Life Sciences , Leukemia , Pharmaceuticals , Small Molecules , Therapeutics 
Excimer-Based Molecular Tool for Detection of Proximally Phosphorylated Protein Sites Cancer , Detection Methods , Fluorescent sensors , Proteins , Sensors & Instrumentation 
Mammalian Membrane Two-Hybrid (MaMTH) Technology: a Novel Protein Interaction and Drug Discovery Tool Cancer , Cell Signaling , Disease Detection , Drug Discovery , Genetics , Membrane Proteins , Neurological Disorders , Protein-Protein Interactions , Proteins 
Measurement of Rodent Interaction with a Cage Lid Cancer , Neurological Disorders , Sensors & Instrumentation , Sensory Systems & Rehabilitation 
MNAzyme-Based Gold Nanoparticle Sensor Cancer , Diagnostics , Disease Detection , Medical Devices , Nanomaterials and Nanoparticles , Patient Care , Point-of-Care , Sensors & Instrumentation 
Multiplexed Genetic Detection with Isothermal Signal Amplification Cancer , Chips , Diagnostics , Disease Detection , Genetics , Infectious Diseases , Nanomaterials and Nanoparticles , Point-of-Care , Polymers , Quantum Dots , Smartphones 
Nanoparticle-based Thermal Contrast Agents Cancer , Diagnostics , Disease Detection , Infectious Diseases , Nanomaterials and Nanoparticles 
ReFilx: Regenerative Filler Matrix for permanent restoration of breast tissue following lumpectomy Biomaterials , Cancer , Companies , Nanomaterials and Nanoparticles , Polymers , Tissue Engineering 
UBA5 Inhibitors for the Treatment of Cancer and Leishmaniasis Cancer , Disease Detection , Drug Discovery , Leukemia , Multiple Myeloma 

VPRI Role

  • Market U of T technologies to industry
  • Negotiate license agreements with interested companies
  • Assist in finding partners and funding to support proof-of-concept and commercialization
  • Support long-term relationships with strategic partners that help develop early-stage discoveries into market-ready technologies and products

VPRI Contact

Staff

Jennifer Fraser

Director, Innovations
Innovations & Partnerships Office (IPO)
(416) 946-5515
Radio Options- Did you find this useful?
Did you find this useful?
Let us know if you found this page useful. Did you find the information you were looking for?